News
Despite Evidence Favoring Direct Oral Anticoagulants Over Warfarin, Adoption in U.S. Clinical Practice Has Been Slow, Yale Study Finds
For decades, patients with atrial fibrillation with a moderate or severe risk for stroke were prescribed the anticoagulant, warfarin. With the emergence of a safer, more effective class of oral anticoagulants, new Yale-led research examines contemporary practices among U.S. clinicians between 2013-2018.